...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

NovaBone Putty MIS Delivery System Approved by FDA for Orthopedic Surgery

| Print |
Wednesday, 06 October 2010 14:00 (UTC + 2)

NovaBonebone_logo

The NovaBone Putty MIS Delivery System is a medical device technology that improves conventional delivery methods of bone graft in orthopedic surgeries

 

Jacksonville, FL, October 6, 2010 / b3c newswire / – NovaBone Products, a medical device company, has announced the U.S. Food and Drug Administration’s (FDA) approval of the NovaBone Putty® MIS Delivery System designed for use in minimally invasive orthopedic procedures.

 

The new system is characteristic of NovaBone Product’s ability to develop medical device technology designed for the unique needs of orthopedic surgeons.  The NovaBone MIS Delivery System improves conventional delivery methods of bone graft substitutes through a syringe pre-loaded with ready-to-use NovaBone Putty and 6mm diameter cannulas at varying lengths. The system was developed for surgeons who require controlled and precise delivery of bone grafting material to the surgical site.

 

The NovaBone Putty MIS Delivery System delivers an osteoconductive matrix while signaling and stimulating osteoblastic activity to the orthopedic surgical site.

 

The product is approved for use in orthopedic surgeries of the extremities, the pelvis and posterolateral spine.

 

“The launch of the MIS Delivery System will be just the beginning of products our company will be offering to spine surgeon, neurosurgeons and orthopedic surgeons,” said Art Wotiz, President of NovaBone Products. “As a growing medical device company, we will introduce a number of new products this year and through 2011 that are based on advancements in bioengineered medical technology.”

 

New products will represent patented medical technology that will keep NovaBone Products in the forefront of the marketplace with orthopedic bone graft options.

 

 

About NovaBone Products

NovaBone Products manufactures the NovaBone medical device brand of orthopedic bone graft products and is headquartered in Jacksonville with operations in Alachua, Florida. The company is dedicated to delivering novel bone graft substitutes based on biomedical engineering that meet the specialized needs of orthopedic surgeons.

 

Contacts:

Arthur Wotiz, This e-mail address is being protected from spambots. You need JavaScript enabled to view it , 904/807-0140

Or Dennis McBride, This e-mail address is being protected from spambots. You need JavaScript enabled to view it , 908-287-2284